Bath & Body Works, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $BBWI in the last 7 days.
No SEC Form 4 filings for $BBWI in the last 30 days.
See all $BBWI insider activity →Wells Fargo analyst Ike Boruchow maintained a Buy rating on Bath & Body Works (BBWI) with a $24.00 price target. On Holding AG (ONON) received a Buy rating from Citi's Paul Lejuez and a $38.00 target from Berenberg Bank. BBWI closed at $16.45, ONON at $29.96. Analyst consensus: BBWI Hold ($22.20 target), ONON Strong Buy ($42.57 target).
Bath & Body Works (BBWI) introduced a new hypoallergenic product line, Essentials, targeting the $100B sensitive skin market. The line includes body washes and lotions, launched on September 28.
Bath & Body Works (BBWI) granted CEO Daniel Heaf a performance stock unit award worth $10 million, or 591,366 shares, tied to stock price targets and relative performance over four years. The award vests based on share prices between $40 and $100 and total shareholder return compared to the S&P 1500 Consumer Discretionary Distribution & Retail Index.
Recent BBWI coverage spans financial news, corporate actions and earnings.
Analyst upgrade and higher price target suggest upside potential.
The new product line could attract price‑sensitive consumers and modestly boost sales.
The award ties CEO compensation to long‑term share performance, potentially aligning incentives with shareholders.
The filing discloses a new, quantified equity incentive tied to specific stock-price thresholds, which can affect near-term sentiment and executive alignment expectations.
Potential activist push could drive short-term volatility and pressure for strategic options.
AlphAI scores every news story that mentions BBWI with an AI model for sentiment and relevance, and aggregates insider trades from Bath & Body Works, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Wells Fargo analyst Ike Boruchow maintained a Buy rating on Bath & Body Works (BBWI) with a $24.00 price target. On Holding AG (ONON) received a Buy rating from Citi's Paul Lejuez and a $38.00 target from Berenberg Bank. BBWI closed at $16.45, ONON at $29.96. Analyst consensus: BBWI Hold ($22.20 target), ONON Strong Buy ($42.57 target).
2 min readBath & Body Works (BBWI) introduced a new hypoallergenic product line, Essentials, targeting the $100B sensitive skin market. The line includes body washes and lotions, launched on September 28.
1 min readBath & Body Works (BBWI) granted CEO Daniel Heaf a performance stock unit award worth $10 million, or 591,366 shares, tied to stock price targets and relative performance over four years. The award vests based on share prices between $40 and $100 and total shareholder return compared to the S&P 1500 Consumer Discretionary Distribution & Retail Index.
1 min readBath & Body Works, Inc. (BBWI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 21, 2026, the Human Capital and Compensation Committee of the Board of Directors of Bath & Body Works, Inc. (
3 min readBarington Capital Group has taken an activist stake in Bath & Body Works (BBWI), pushing for a potential sale, share repurchases, and board seats, citing undervaluation. Shares closed at $17.19, down 31.78% over a year. Analysts and models suggest fair value estimates between $24.06 and $39.78, indicating a significant discount. The company faces risks like mall exposure and shifting consumer tastes.
3 min readBarington Capital Group disclosed a stake in Bath & Body Works, urging a sale, share repurchases, and board changes. The activist's push challenges the company's capital allocation strategy, focusing on digital upgrades and expansion. Analysts project 2029 revenue of $7.6B and earnings of $708.4M, with a 53% potential upside. Risks include digital underperformance and margin pressures.
3 min readBest Buy (BBY) reported Q2 revenue of $9.78B, up 3.6% YoY, beating estimates. Its stock rose 3.7% post-earnings. Dick's (DKS) reported $5.59B revenue, up 53.2% YoY, missing estimates. Its stock fell 24.7%. Sally Beauty (SBH) reported flat revenue of $935.5M, meeting expectations. Bath & Body Works (BBWI) reported $1.51B revenue, down 2.3% YoY, beating estimates. Its stock rose 4.8%.
3 min readBarington Capital, holding over 1M shares, urges Bath & Body Works to explore a sale, citing undervaluation and weak financial performance. The retailer's shares have dropped 78% since 2021, with net income down 50%. Barington also proposes share buybacks and board representation.
2 min readBath & Body Works (BBWI) shares rose 2.3% in extended trading after Barington Capital disclosed a 1M-share stake and urged a sale, citing leadership turnover and undervaluation. The company's stock has fallen 78% since its 2021 spin-off, with net income dropping 50%. BBWI management remains open to shareholder feedback.
2 min readBath & Body Works (BBWI) reported Q2 2026 net income of $118M on $1.51B sales, completed a $382.93M share buyback, and updated guidance for a 4% to 2.5% decline in full-year sales but higher EPS. The company launched the Reserve Collection, focusing on product innovation. Analysts debate the stock's value, with projections ranging from $7.2B to $7.6B revenue by 2029.
2 min read
